Myovant Sciences Ltd. Deferred Tax Assets, Valuation Allowance
Myovant Sciences Ltd. had Deferred Tax Assets, Valuation Allowance of $244.19 million as of 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2022-05-11
- 2022-03-31: Deferred Tax Assets, Valuation Allowance $244.19M.
- 2021-03-31: Deferred Tax Assets, Valuation Allowance $207.86M.
- 2020-03-31: Deferred Tax Assets, Valuation Allowance $157.53M.
- 2019-03-31: Deferred Tax Assets, Valuation Allowance $92.33M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2022-03-31 | $244.19M 10-K · filed 2022-05-11 |
| 2021-03-31 | $207.86M 10-K · filed 2022-05-11 |
| 2020-03-31 | $157.53M 10-K · filed 2021-05-11 |
| 2019-03-31 | $92.33M 10-K · filed 2020-05-18 |
| 2018-03-31 | $21.37M 10-K · filed 2019-05-24 |
| 2017-03-31 | $7.40M 10-K · filed 2018-06-07 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-14 |